These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Recent advances in contraception and family planning]. Faúndes A Salud Publica Mex; 1992; 34(1):5-17. PubMed ID: 1549790 [TBL] [Abstract][Full Text] [Related]
28. Statement on intrauterine devices (IUDs). International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1987 Dec; 21(6):3-5. PubMed ID: 12268853 [TBL] [Abstract][Full Text] [Related]
29. I have an IUD--what should I do? Contracept Technol Update; 1986 Jul; 7(7 Suppl):1S-4S. PubMed ID: 12281105 [TBL] [Abstract][Full Text] [Related]
30. [The end of IUD marketing in the United States: what does it mean for American women?]. Forrest JD Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479 [TBL] [Abstract][Full Text] [Related]
31. [Intrauterine contraception in women over 35-years old: comparison between copper and progesterone IUDs]. Calzolari E; Galoppi P; Masala L; Parisi C; Iannucci D; Salmaggi P; Custo GM; Zichella L Patol Clin Ostet Ginecol; 1985; 13(1):49-56. PubMed ID: 12342024 [TBL] [Abstract][Full Text] [Related]
32. Mineral deposits formation in bioactive IUD's. Huacuja L; Delgado NM; Aznar R; Rosado A Adv Contracept Deliv Syst; 1987; 3(2-3):251-7. PubMed ID: 12268656 [TBL] [Abstract][Full Text] [Related]
33. Progestasert - a new intrauterine contraceptive device. Med Lett Drugs Ther; 1976 Jul; 18(16):65-6. PubMed ID: 950949 [No Abstract] [Full Text] [Related]
34. [Performance and indications of progesterone-releasing IUDs]. Cittadini E Contracept Fertil Sex (Paris); 1980 Nov; 8(11):841-5. PubMed ID: 12336584 [TBL] [Abstract][Full Text] [Related]
35. [Intrauterine contraception from the viewpoint of an ambulatory gynecologic department]. Hagen P Z Arztl Fortbild (Jena); 1981 Sep; 75(17):800-4. PubMed ID: 7345787 [TBL] [Abstract][Full Text] [Related]
36. [Postplacental application of 5 different types of intrauterine devices]. Reynoso L; Arevalo N; Lara R; Aznar R Ginecol Obstet Mex; 1982 May; 50(301):107-10. PubMed ID: 7182224 [TBL] [Abstract][Full Text] [Related]
37. [Non-hormonal methods of female contraception]. Audebert AJ Rev Prat; 1987 Sep; 37(38):2255-65. PubMed ID: 3659792 [TBL] [Abstract][Full Text] [Related]
38. [Use of the bio-active intrauterine devices TCu 200 and IPCS 52 during the post-partum period]. Lavin P; Bravo C; Waskaz C; Andrade MI; Bravo M; Caceres R; Castro J; Miranda L; Namur L; Olmos G Contracept Fertil Sex (Paris); 1984 Mar; 12(3):483-8. PubMed ID: 12265945 [TBL] [Abstract][Full Text] [Related]
39. The Alza T IPCS 52, a longer acting progesterone IUD: safety and efficacy compared to the TCu22OC and multiload 250 in two randomized multicentre trials. The World Health Organization's special programme of research, development and research training in human reproduction. Task Force on intrauterine devices for fertility regulation. Clin Reprod Fertil; 1983 Jun; 2(2):113-28. PubMed ID: 6367929 [TBL] [Abstract][Full Text] [Related]
40. Increased retention of intrauterine contraceptive devices medicated with indomethacin and medroxyprogesterone acetate. Von Dadelszen P; Hurst PR; Peplow PV Proc Univ Otago Med Sch; 1981 Oct; 59(3):101-3. PubMed ID: 12264137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]